Population Health Sciences

You are here

Home > Publications > Publications

Publications

Found 438 results
[ Author(Asc)] Title Type Year
Filters: Filter is   [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
Murthy SB, Wu X, Díaz I, Parasram M, Parikh NS, Iadecola C, Merkler AE, Falcone GJ, Brown S, Biffi A et al..  2020.  Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events.. Stroke. 51(5):1464-1469.
Murphy SM, Morgan JR, Jeng PJ, Schackman BR.  2019.  Will converting naloxone to over-the-counter status increase pharmacy sales? Health Serv Res. 54(4):764-772.
Murphy S, Friesner DL, Rosenman R, Waslo CS, Au J, Tanne E.  2019.  Emergency department utilization among individuals with idiopathic intracranial hypertension.. Int J Health Care Qual Assur. 32(1):152-163.
Murphy SM, McCollister KE, Leff JA, Yang X, Jeng PJ, Lee JD, Nunes EV, Novo P, Rotrosen J, Schackman BR.  2018.  Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse.. Ann Intern Med.
Mullangi S, Press MJ, Ryan AM.  2019.  A delicate balance: Accountability for very high-cost patients in new payment models.. Healthc (Amst). :100366.
Mullangi S, Bhandari R, Thanaporn P, Christensen M, Kronick S, Nallamothu BK.  2020.  Perceptions of resuscitation care among in-hospital cardiac arrest responders: a qualitative analysis.. BMC Health Serv Res. 20(1):145.
Mullangi S, Kaushal R, Ibrahim SA.  2019.  Equity in the Age of Health Care Information Technology and Innovation: Addressing the Digital Divide.. Med Care. 57 Suppl 6 Suppl 2:S106-S107.
Morgan JR, Schackman BR, Weinstein ZM, Walley AY, Linas BP.  2019.  Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort.. Drug Alcohol Depend. 200:34-39.
Mones E, Stopczynski A, Pentland A'Sandy', Hupert N, Lehmann S.  2018.  Optimizing targeted vaccination across cyber-physical networks: an empirically based mathematical simulation study.. J R Soc Interface. 15(138)
Molina AM, van der Mijn JC, Christos P, Wright J, Thomas C, Dutcher JP, Nanus DM, Tagawa ST, Gudas LJ.  2020.  NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma.. Invest New Drugs.
Min JYoung, Williams N, Simmons W, Banerjee S, Wang F, Zhang Y, Reese AB, Mushlin AI, Flory JH.  2022.  Baseline haemoglobin A1c and the risk of COVID-19 hospitalization among patients with diabetes in the INSIGHT Clinical Research Network.. Diabet Med. 39(5):e14815.
Min JY, Simmons W, Banerjee S, Wang F, Williams N, Zhang Y, Reese AB, Mushlin AI, Flory JH.  2022.  Association between antidiabetic drug use and the risk of COVID-19 hospitalization in the INSIGHT Clinical Research Network in New York City.. Diabetes Obes Metab. 24(7):1402-1405.
Merkler AE, Parikh NS, Mir S, Gupta A, Kamel H, Lin E, Lantos J, Schenck EJ, Goyal P, Bruce SS et al..  2020.  Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza.. JAMA Neurol.
Meisel ZF, Mitchell J, Polsky D, Boualam N, McGeoch E, Weiner J, Miclette M, Purtle J, Schackman B, Cannuscio CC.  2019.  Strengthening partnerships between substance use researchers and policy makers to take advantage of a window of opportunity.. Subst Abuse Treat Prev Policy. 14(1):12.
Meinhofer A, Hinde JM, Ali MM.  2020.  Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings.. J Subst Abuse Treat. 110:9-17.
Meinhofer A, Angleró-Díaz Y.  2019.  Trends in Foster Care Entry Among Children Removed From Their Homes Because of Parental Drug Use, 2000 to 2017.. JAMA Pediatr.
Meinhofer A.  2020.  Pediatric Implications of Opioid-Specific Parental Drug Use-Reply.. JAMA Pediatr.
Meinhofer A, Williams ARobin, Johnson P, Schackman BR, Bao Y.  2019.  Prescribing decisions at buprenorphine treatment initiation: Do they matter for treatment discontinuation and adverse opioid-related events? J Subst Abuse Treat. 105:37-43.
Mehta B, Luo Y, Xu J, Sammaritano L, Salmon J, Lockshin M, Goodman S, Ibrahim S.  2019.  Trends in Maternal and Fetal Outcomes Among Pregnant Women With Systemic Lupus Erythematosus in the United States: A Cross-sectional Analysis.. Ann Intern Med. 171(3):164-171.
Mehta B, Goodman S, Ho K, Parks M, Ibrahim SA.  2020.  Community Deprivation Index and Discharge Destination after Elective Hip Replacement.. Arthritis Care Res (Hoboken).
Mehta B, Ho K, Ling V, Goodman S, Parks M, Ravi B, Banerjee S, Wang F, Ibrahim S, Cram P.  2022.  Are Income-based Differences in TKA Use and Outcomes Reduced in a Single-payer System? A Large-database Comparison of the United States and Canada. Clin Orthop Relat Res. 480(9):1636-1645.
Mehta B, Goodman S, DiCarlo E, Jannat-Khah D, J Gibbons AB, Otero M, Donlin L, Pannellini T, Robinson WH, Sculco P et al..  2023.  Machine learning identification of thresholds to discriminate osteoarthritis and rheumatoid arthritis synovial inflammation.. Arthritis Res Ther. 25(1):31.
Mehta BY, Ibrahim S, Briggs W, Efthimiou P.  2019.  Racial/Ethnic variations in morbidity and mortality in Adult Onset Still's Disease: An analysis of national dataset.. Semin Arthritis Rheum.
McNeely J, Troxel AB, Kunins HV, Shelley D, Lee JD, Walley A, Weinstein ZM, Billings J, Davis NJ, Marcello RKalyanaram et al..  2019.  Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment.. Addict Sci Clin Pract. 14(1):5.
McIntire PJ, Zhong E, Patel A, Khani F, D'Alfonso TM, Chen Z, Shin SJ, Ginter PS.  2019.  Hotspot enumeration of CD8+ tumor-infiltrating lymphocytes using digital image analysis in triple-negative breast cancer yields consistent results.. Hum Pathol. 85:27-32.